LICENSE AGREEMENTLicense Agreement • March 12th, 2010 • Genvec Inc • Pharmaceutical preparations • Illinois
This License Agreement (“Agreement”), dated May 26, 1993, between ARCH Development Corporation, an Illinois not-for-profit corporation (“ARCH”) and GenVec, Inc., a Delaware corporation (“Licensee”).
AWARD/CONTRACT 1. THIS CONTRACT IS A RATED ORDER UNDER DPAS (15 CFR 350) RATING PAGE 1 OF PAGES 3Negotiated Agreement • March 12th, 2010 • Genvec Inc • Pharmaceutical preparations
September 21, 1999Genvec Inc • March 12th, 2010 • Pharmaceutical preparations
SECOND AMENDMENT TO LICENSE AGREEMENT The University of Chicago, Dana Farber Cancer Institute and GenVec CorporationLicense Agreement • March 12th, 2010 • Genvec Inc • Pharmaceutical preparations
This Amendment to the License Agreement is entered into as of January 20, 2005, by and between The University of Chicago ("University"), Dana Farber Cancer Institute ("DFCI") and GenVec Corporation, a Delaware corporation ("GenVec") (University, DFCI and GenVec may be referred to individually as a "Party" and collectively as the "Parties");
FIRST AMENDMENT to the May 26, 1993 License Agreement between ARCH Development Corporation and GenVec, Inc.Genvec Inc • March 12th, 2010 • Pharmaceutical preparations
This Amendment is effective as of December 31, 2001 between the University of Chicago (the “University”), Dana Farber Cancer Institute, Inc. (“DFCI”), and GenVec Corporation, a Delaware Corporation (“GenVec”).
